bmy-25801 failed to reveal any d2-dopamine receptor antagonist properties in several pharmacological tests ( catalepsy , apomorphine stereotypy , serum prolactin , striatal dihydroxyphenylacetic acid and [ 3h ] spiperone displacement ) whereas metoclopramide was uniformly active in these tests .
C2917388
d2-dopamine receptor antagonist
C0025853
metoclopramide